# Elbit Imaging Ltd.

> Elbit Imaging Ltd. is a VC fund in Tel Aviv backing Software and Publishing. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tel Aviv, Israel
- Total investments: 6
- Last investment: Dec 2017
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/elbit-imaging-ltd./
- Website: http://www.elbitimaging.com/

Elbit Imaging Ltd. is a VC fund in Tel Aviv focused on Software and Publishing. Elbit Imaging Ltd is an Israel-based holding company. It operates in the fields of Commercial and Entertainment Centers, engaged in the initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector; United States Real Property, investing in commercial realproperty in the United States; Hotels, engaged in the management and operation of hotels; Medical Industries, engaged in research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; Residential Projects, engaged in the initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, and Fashion Apparel, engaged in the Distribution and marketing of fashion apparel and accessories.

## Contacts

5 contacts available for Elbit Imaging Ltd.. Shizune tracks 2 team members at Elbit Imaging Ltd.. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/elbit-imaginh-ltd?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 1 | 17% |
| Publishing | 1 | 17% |
| Health Care | 1 | 17% |
| Therapeutics | 1 | 17% |
| Biotechnology | 1 | 17% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 17% |
| Series B | 1 | 17% |
| Series D | 1 | 17% |
| Series E | 1 | 17% |
| Funding Round | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 1 | 17% |
| United States | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ifat Avidan | Vp public relations | 0 | — |
| Shimon Yitzhaki | Chairman of the Board of Directors | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| InSightec | InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery.ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment ofsymptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world. | $150M | Series E | Dec 14, 2017 |  |
| InSightec | InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery.ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment ofsymptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world. | $59M | Series D | Dec 15, 2014 |  |
| InSightec | InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery.ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment ofsymptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world. | $15M | Series B | Mar 19, 2009 |  |
| InSightec | InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery.ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment ofsymptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world. | $30M |  | Nov 30, 2007 |  |
| InSightec | InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery.ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment ofsymptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world. | $40M |  | Dec 01, 2001 |  |
| Olive Software | Olive Software develops and markets an enterprise level content management platform for publishers and libraries, featuring an automatic transformation of new and printed publications to XML, long term digital archiving, and powerful multi-media electronic publishing system. The platform offers multiple vertical applications driven from a singleworkflow and single XML repository. | $5M | Series A | Oct 02, 2000 |  |

6 of 6 investments shown.

## Co-investors
- GE Healthcare — VC Fund, 3 deals together
- [GEOC](https://shizune.co/investors/profile/geoc-hengtong-investment-limited-partnership) — VC Fund, 2 deals together
- York Capital Management — VC Fund, 2 deals together
- Boston MedTech Advisors — VC Fund, 1 deal together
- Focus Holdings — VC Fund, 1 deal together
- [GE Capital](https://shizune.co/investors/profile/ge-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Elbit Imaging Ltd. invest in?

Elbit Imaging Ltd. invests primarily in Software, Publishing and Health Care startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Elbit Imaging Ltd.?

Public channels for Elbit Imaging Ltd. include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Elbit Imaging Ltd.?

The team at Elbit Imaging Ltd. includes Ifat Avidan (Vp public relations) and Shimon Yitzhaki (Chairman of the Board of Directors). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co